期刊文献+

Trabeculectomy with large area mitomycin-C application as a first-line treatment in advanced glaucoma: retrospective review 被引量:6

Trabeculectomy with large area mitomycin-C application as a first-line treatment in advanced glaucoma: retrospective review
下载PDF
导出
摘要 AIM: To evaluate the outcomes of trabeculectomy with large area mitomycin-C(MMC) application as a first line treatment in advanced glaucoma. ·METHODS: The records of 55 patients with severe visual field defects undergoing trabeculectomy were retrospectively reviewed. The patients were classified as first-line therapy to either early trabeculectomy(initial trabeculectomy-Group 1) or long term medical therapy followed by trabeculectomy(primary trabeculectomy-Group 2). Trabeculectomy was performed with large-area MMC application. Intraocular pressure(IOP) values,visual acuities,mean deviations,morphology and function of the blebs,necessity for anti-glaucomatous medications and surgical complications were reported. ·RESULTS: There were 20 eyes of 18 patients in Group 1 and 37 eyes of 37 patients in Group 2. The mean preoperative IOPs in Groups 1 and 2 were 40.2±10.0mmHg(27-68mmHg) and 29.0±4.4mmHg(21-41mmHg),respectively(P=0.001). Average preoperative mean deviations(MD) in Groups 1 and 2 were 17.4±2.8dB(13.3-23dB) and 17.9± 2.4dB(13.7-23.2dB),respectively(P=0.441). Postoperative IOPs significantly decreased and were comparable in both Groups. The mean number of medications was significantly higher in Group 2(P =0.005). No cystic bleb formation was observed in Group 1,whereas 4 patients from Group 2(10.8%) developed cystic bleb(P =0.040). No visually devastating complication has occurred in both Groups. ·CONCLUSION: Initial trabeculectomy with large areaMMC application might be applied in patients with advanced glaucoma with low complication rates. Long-term topically applied anti-glaucomatous medications seem to increase the risk of cystic bleb formation. AIM: To evaluate the outcomes of trabeculectomy with large area mitomycin-C(MMC) application as a first line treatment in advanced glaucoma. ·METHODS: The records of 55 patients with severe visual field defects undergoing trabeculectomy were retrospectively reviewed. The patients were classified as first-line therapy to either early trabeculectomy(initial trabeculectomy-Group 1) or long term medical therapy followed by trabeculectomy(primary trabeculectomy-Group 2). Trabeculectomy was performed with large-area MMC application. Intraocular pressure(IOP) values,visual acuities,mean deviations,morphology and function of the blebs,necessity for anti-glaucomatous medications and surgical complications were reported. ·RESULTS: There were 20 eyes of 18 patients in Group 1 and 37 eyes of 37 patients in Group 2. The mean preoperative IOPs in Groups 1 and 2 were 40.2±10.0mmHg(27-68mmHg) and 29.0±4.4mmHg(21-41mmHg),respectively(P=0.001). Average preoperative mean deviations(MD) in Groups 1 and 2 were 17.4±2.8dB(13.3-23dB) and 17.9± 2.4dB(13.7-23.2dB),respectively(P=0.441). Postoperative IOPs significantly decreased and were comparable in both Groups. The mean number of medications was significantly higher in Group 2(P =0.005). No cystic bleb formation was observed in Group 1,whereas 4 patients from Group 2(10.8%) developed cystic bleb(P =0.040). No visually devastating complication has occurred in both Groups. ·CONCLUSION: Initial trabeculectomy with large areaMMC application might be applied in patients with advanced glaucoma with low complication rates. Long-term topically applied anti-glaucomatous medications seem to increase the risk of cystic bleb formation.
出处 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2014年第1期104-109,共6页 国际眼科杂志(英文版)
关键词 TRABECULECTOMY advanced glaucoma large area mitomycin-C application trabeculectomy, advanced glaucoma, large area mitomycin-C application
  • 相关文献

参考文献8

  • 1Brian A. Francis,Kuldev Singh,Shan C. Lin,Elizabeth Hodapp,Henry D. Jampel,John R. Samples,Scott D. Smith.Novel Glaucoma Procedures[J]. Ophthalmology . 2011 (7)
  • 2David C. Musch,Brenda W. Gillespie,Paul R. Lichter,Leslie M. Niziol,Nancy K. Janz.Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study[J]. Ophthalmology . 2009 (2)
  • 3Merih?nol,ZeynepAkta?,BeratiHasanreiso?lu.Enhancement of the success rate in trabeculectomy: large‐area mitomycin‐C application[J]. Clinical & Experimental Ophthalmology . 2008 (4)
  • 4Karanjit Kooner.Risk factors for progression to blindness in high tension primary open angle glaucoma: Comparison of blind and nonblind subjects[J]. Clinical Ophthalmology . 2008 (Issue 4)
  • 5Richard J. Hesse.Risk of Sudden Visual Loss After Filtration Surgery in End-Stage Glaucoma[J]. American Journal of Ophthalmology . 2006 (5)
  • 6Takashi Shigeeda,Atsuo Tomidokoro,Yi-Ning Chen,Shiroaki Shirato,Makoto Araie.Long-term Follow-up of Initial Trabeculectomy With Mitomycin C for Primary Open-angle Glaucoma in Japanese Patients[J]. Journal of Glaucoma . 2006 (3)
  • 7Paul R Lichter,David C Musch,Brenda W Gillespie,Kenneth E Guire,Nancy K Janz,Patricia A Wren,M.P.H.Richard P Mills.Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery[J]. Ophthalmology . 2001 (11)
  • 8Christophe Baudouin,Pierre-Jean Pisella,Kathleen Fillacier,Marie Goldschild,Frank Becquet,Magda De Saint Jean,Alain Béchetoille.Ocular surface inflammatory changes induced by topical antiglaucoma drugs[J]. Ophthalmology . 1999 (3)

共引文献1

同被引文献32

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部